|Articles|November 1, 2003
VACCINE LAUNCH EXPECTED
CancerVax expects to launch its therapeutic melanoma vaccine and lead product candidate Canvaxin by 2006.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Related Articles
- Day 3 Recap: Maui Derm NP+PA Fall 2025
September 22nd 2025
- A Practical Update on Psoriasis and Vitiligo Treatment
September 22nd 2025
- Adapting to the Age of AI in Clinical Dermatology
September 22nd 2025
- Expert Insights on Uncommon Dermatoses from Walter Liszewski, MD
September 22nd 2025
- Nail Pathology in Clinical Practice with Phoebe Rich, MD
September 22nd 2025
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times - Dermatology News and Clinical Insights
1
A Practical Update on Psoriasis and Vitiligo Treatment
2
Beyond the Rash: What Dermatologists Need to Know About the World of Infectious Diseases
3
Adapting to the Age of AI in Clinical Dermatology
4
Nail Pathology in Clinical Practice with Phoebe Rich, MD
5